Jojo Health, Inc. — SEC Form D Filing

Jojo Health, Inc. filed an SEC Form D on September 9, 2026, reporting $50K raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
September 9, 2026
Amount reported
$50K
Round stage
Seed
Industry
Health Technology
Website
https://jojo.health/

What the company does

Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Seniors face challenges with early detection of cognitive changes, which can impact their ability to maintain independence.

Solution

Jojo is a voice AI device that uses cognitive testing and vocal biomarker analysis within casual conversation to track cognitive function and surface early signs of cognitive drift.

Why now

Advances in AI, particularly voice AI and natural language processing, combined with growing awareness of proactive brain health, make it possible to offer continuous, non-invasive cognitive monitoring at home.

Verdict

This cleared because investors saw a low-cost, low-risk way to explore voice AI's potential in a clear, underserved market segment, not because the technology itself was fully de-risked or unique. They were implicitly betting on the continued growth of aging-in-place trends and the eventual commoditization of voice biomarker analysis for consumer health. What limited upside or durability was the lack of immediate clinical validation and the potential for larger tech platforms to absorb similar capabilities.

Source: SEC EDGAR Form D filing